Lipopolysaccharide priming enhances expression of effectors of immune defence while decreasing expression of pro-inflammatory cytokines in mammary epithelia cells from cows

BMC Genomics

Volumn 13, Issue 1, 2012, Pages

  Günther, Juliane ^a   Petzl, Wolfram ^b   Zerbe, Holm ^b   Schuberth, Hans Joachim ^c   Koczan, Dirk ^d   Goetze, Leopold ^e   Seyfert, Hans Martin ^a  

^a LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^d UNIVERSITY OF ROSTOCK   (Germany)

^e PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 8; LINGUAL ANTIMICROBIAL PEPTIDE; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE; MUCIN 1; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RANTES; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CCL5 GENE; CELL CULTURE; CONTROLLED STUDY; COW; CXCL8 GENE; DAF GENE; DOWN REGULATION; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; IL1B GENE; IL6 GENE; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; IRF7 GENE; LAP GENE; MICROARRAY ANALYSIS; MUC1 GENE; NONHUMAN; NOS2 GENE; NUCLEOTIDE SEQUENCE; SLPI GENE; TGM1 GENE; TGM3 GENE; TNF ALPHA GENE; UPREGULATION; ANIMAL; BOVINE MASTITIS; CATTLE; CELL DEATH; CLUSTER ANALYSIS; DRUG EFFECT; EPITHELIUM CELL; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; UDDER;

ESCHERICHIA COLI;

ANIMALS; CATTLE; CELL DEATH; CELLS, CULTURED; CLUSTER ANALYSIS; CYTOKINES; EPITHELIAL CELLS; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; MAMMARY GLANDS, ANIMAL; MASTITIS, BOVINE; TRANSCRIPTOME;

EID: 84859270706     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-13-17     Document Type: Article

References (54)

1. Burvenich C, Van M, Mehrzad J, ez-Fraile A, Duchateau L. Severity of E. coli mastitis is mainly determined by cow factors. Vet Res 2003, 34:521-564. 10.1051/vetres:2003023, 14556694.
2. Vangroenweghe F, Lamote I, Burvenich C. Physiology of the periparturient period and its relation to severity of clinical mastitis. Domest Anim Endocrinol 2005, 29:283-293. 10.1016/j.domaniend.2005.02.016, 15950428.
3. Gonzalez RN, Cullor JS, Jasper DE, Farver TB, Bushnell RB, Oliver MN. Prevention of clinical coliform mastitis in dairy cows by a mutant Escherichia coli vaccine. Can J Vet Res 1989, 53:301-305. 1255715, 2670166.
4. Hogan JS, Weiss WP, Smith KL, Todhunter DA, Schoenberger PS, Sordillo LM. Effects of an Escherichia coli J5 vaccine on mild clinical coliform mastitis. J Dairy Sci 1995, 78:285-290. 10.3168/jds.S0022-0302(95)76636-X, 7745148.
5. Wilson DJ, Grohn YT, Bennett GJ, Gonzalez RN, Schukken YH, Spatz J. Comparison of J5 vaccinates and controls for incidence, etiologic agent, clinical severity, and survival in the herd following naturally occurring cases of clinical mastitis. J Dairy Sci 2007, 90:4282-4288. 10.3168/jds.2007-0160, 17699047.
6. Wilson DJ, Mallard BA, Burton JL, Schukken YH, Grohn YT. Association of Escherichia coli J5-specific serum antibody responses with clinical mastitis outcome for J5 vaccinate and control dairy cattle. Clin Vaccine Immunol 2009, 16:209-217. 10.1128/CVI.00324-08, 2643543, 19052158.
7. Wilson DJ, Grohn YT, Bennett GJ, González RN, Schukken YH, Spatz J. Milk production change following clinical mastitis and reproductive performance compared among J5 vaccinated and control dairy cattle. J Dairy Sci 2008, 91:3869-3879. 10.3168/jds.2008-1405, 18832209.
8. Klostermann K, Crispie F, Flynn J, Ross RP, Hill C, Meaney W. Intramammary infusion of a live culture of Lactococcus lactis for treatment of bovine mastitis: comparison with antibiotic treatment in field trials. J Dairy Res 2008, 75:365-373.
9. Shuster DE, Harmon RJ. Lactating cows become partially refractory to frequent intramammary endotoxin infusions - recovery of milk-yield Despite a persistently high somatic-cell count. Res Vet Sc 1991, 51:272-277.
10. Lohuis JACM, Kremer W, Schukken YH, Smit JAH, Verheijden JHM, Brand A, Van Miert ASJP. Growth of Escherichia coli in milk from endotoxin-induced mastitic quarters and the course of subsequent experimental Escherichia coli mastitis in the cow. J Dairy Sci 1990, 73:1508-1514. 10.3168/jds.S0022-0302(90)78818-2, 2200810.
11. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007, 447:972-978.
12. Ziegler-Heitbrock L. The p50-homodimer mechanism in tolerance to LPS. J Endotoxin Res 2001, 7:219-222.
13. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009, 30:475-487. 10.1016/j.it.2009.07.009, 19781994.
14. del Fresno C, García-Rio F, Gómez-Piña V, Soares-Schanoski A, Fernández-Ruíz I, Jurado T, Kajiji T, Shu C, Marín E, Gutierrez del Arroyo A, Prados C, Arnalich F, Fuentes-Prior P, Biswas SK, López-Collazo E. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J Immunol 2009, 182:6494-6507. 10.4049/jimmunol.0803350, 19414804.
15. Monneret G, Finck ME, Venet F, Debard AL, Bohé J, Bienvenu J, Lepape A. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 2004, 95:193-198. 10.1016/j.imlet.2004.07.009, 15388260.
16. Strandberg Y, Gray C, Vuocolo T, Donaldson L, Broadway M, Tellam R. Lipopolysaccharide and lipoteichoic acid induce different innate immune responses in bovine mammary epithelial cells. Cytokine 2005, 31:72-86. 10.1016/j.cyto.2005.02.010, 15882946.
17. Günther J, Koczan D, Yang W, Nürnberg G, Repsilber D, Schuberth HJ, Park Z, Maqbool N, Molenaar A, Seyfert HM. Assessment of the immune capacity of mammary epithelial cells: comparison with mammary tissue after challenge with Escherichia coli. Vet Res 2009, 40:31. 10.1051/vetres/2009014, 2695127, 19321125.
18. Yang W, Molenaar AJ, Kurts-Ebert B, Seyfert HM. NF-κB factors are essential, but not the switch, for pathogen-related induction of the bovine β-defensin 5-encoding gene in mammary epithelial cells. Mol Immunol 2006, 43:210-225. 10.1016/j.molimm.2005.02.003, 16199258.
19. Petzl W, Zerbe H, Günther J, Yang W, Seyfert HM, Nürnberg G, Schuberth HJ. Escherichia coli, but not Staphylococcus aureus triggers an early increased expression of factors contributing to the innate immune defense in the udder of the cow. Vet Res 2008, 39:18. 10.1051/vetres:2007057, 18258172.
20. Gray C, Strandberg Y, Donaldson L, Tellam RL. Bovine mammary epithelial cells, initiators of innate immune response to mastitis. Aust J Exp Agr 2005, 45:757-761.
21. Lahouassa H, Moussay E, Rainard P, Riollet C. Differential cytokine and chemokine responses of bovine mammary epithelial cells to Staphylococcus aureus and Escherichia coli. Cytokine 2007, 38:12-21. 10.1016/j.cyto.2007.04.006, 17532224.
22. Günther J, Esch K, Poschadel N, Petzl W, Zerbe H, Mitterhuemer S, Blum H, Seyfert HM. Comparative kinetics of Escherichia coli- and Staphylococcus aureus-specific activation of key immune pathways in mammary epithelial cells demonstrates that S. aureus elicits a delayed response dominated by interleukin-6 (IL-6) but not by IL-1A or tumor necrosis factor alpha. Infect Immun 2011, 79:695-707. 10.1128/IAI.01071-10, 3028868, 21115717.
23. Petzl W, Günther J, Pfister T, Sauter-Louis C, Goetze L, von Aulock S, Hafner-Marx A, Schuberth HJ, Seyfert HM, Zerbe H. Lipopolysaccharide infusion into the udder reduces the inflammatory response and the bacterial load after consecutive E. coli challenge . Innate Immun 10.1177/1753425911422407, 21990573.
24. Tripathi A, King C, de la Morenas A, Perry VK, Burke B, Antoine GA, Hirsch EF, Kavanah M, Mendez J, Stone M, Gerry NP, Lenburg ME, Rosenberg CL. Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients. Int J Cancer 2008, 122:1557-1566.
25. Lin SC, Lo YC, Wu H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 2010, 465:885-890. 10.1038/nature09121, 2888693, 20485341.
26. O'Neill LAJ, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 2007, 7:353-364. 10.1038/nri2079, 17457343.
27. Günther J, Liu S, Esch K, Schuberth HJ, Seyfert HM. Stimulated expression of TNF-α and IL-8, but not of Lingual antimicrobial peptide reflects the concentration of pathogens contacting bovine Mammary Epithelial Cells. Vet Immunol Immunopathol 2010, 135:152-157. 10.1016/j.vetimm.2009.11.004, 19963279.
28. Yang W, Zerbe H, Petzl W, Brunner RM, Günther J, Draing C, von Aulock S, Schuberth HJ, Seyfert HM. Bovine TLR2 and TLR4 properly transduce signals from Staphylococcus aureus and E. coli, but S. aureus fails to both activate NF-κB in mammary epithelial cells and to quickly induce TNF-α and interleukin-8 (CXCL8) expression in the udder. Mol Immunol 2008, 45:1385-1397. 10.1016/j.molimm.2007.09.004, 17936907.
29. Gouwy M, Struyf S, Berghmans N, Vanormelingen C, Schols D, Van Damme J. CXCR4 and CCR5 ligands cooperate in monocyte and lymphocyte migration and in inhibition of dual-tropic (R5/X4) HIV-1 infection. Eur J Immunol 2011, 41:963-973. 10.1002/eji.201041178, 21381021.
30. Carman CV, Springer TA. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol 2004, 167:377-388. 10.1083/jcb.200404129, 2172560, 15504916.
31. Gereke M, Jung S, Buer J, Bruder D. Alveolar type II epithelial cells present antigen to CD4+ T cells and induce Foxp3+ regulatory T cells. Am J Respir Crit Care Med 2009, 179:344-355. 10.1164/rccm.200804-592OC, 19096007.
32. Liu S, Shi X, Bauer I, Günther J, Seyfert HM. Lingual antimicrobial peptide and IL-8 expression are oppositely regulated by the antagonistic effects of NF-κB p65 and C/EBPβ in mammary epithelial cells. Mol Immunol 2011, 48:895-908. 10.1016/j.molimm.2010.12.018, 21255844.
33. Elsik CG, Tellam RL, Worley KC. The Bovine Genome Sequencing and Analysis Consortium The genome sequence of taurine cattle: a window to ruminant biology and evolution. Science 2009, 324:522-528. 2943200, 19390049, The Bovine Genome Sequencing and Analysis Consortium.
34. Swanson K, Gorodetsky S, Good L, Davis S, Musgrave D, Stelwagen K, Farr V, Molenaar A. Expression of a beta-defensin mRNA, lingual antimicrobial peptide, in bovine mammary epithelial tissue is induced by mastitis. Infect Immun 2004, 72:7311-7314. 10.1128/IAI.72.12.7311-7314.2004, 529112, 15557657.
35. Wiesner J, Vilcinskas A. Antimicrobial peptides: the ancient arm of the human immune system. Virulence 2010, 1:440-464. 10.4161/viru.1.5.12983, 21178486.
36. Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM, Lacomis L, Erdjument-Bromage H, Tempst P, Wright CD, Ding A. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 2002, 111:867-878. 10.1016/S0092-8674(02)01141-8, 12526812.
37. Actor JK, Hwang SA, Kruzel ML. Lactoferrin as a natural immune modulator. Curr Pharm Des 2009, 15:1956-1973. 10.2174/138161209788453202, 2915836, 19519436.
38. Kruzel ML, Harari Y, Chen CY, Castro GA. Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice. Inflammation 2000, 24:33-44. 10.1023/A:1006935908960, 10704062.
39. Taylor-Papadimitriou J, Burchell JM, Plunkett T, Graham R, Correa I, Miles D, Smith M. MUC1 and the immunobiology of cancer. J Mammary Gland Biol Neoplasia 2002, 7:209-221. 10.1023/A:1020360121451, 12463741.
40. Li X, Wang L, Nunes DP, Troxler RF, Offner GD. Pro-inflammatory cytokines up-regulate MUC1 gene expression in oral epithelial cells. J Dent Res 2003, 82:883-887. 10.1177/154405910308201107, 14578499.
41. Elli L, Bergamini CM, Bardella MT, Schuppan D. Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver. Dig Liver Dis 2009, 41:541-550. 10.1016/j.dld.2008.12.095, 19195940.
42. Dinarello CA. Proinflammatory Cytokines. Chest 2000, 118:503-508. 10.1378/chest.118.2.503, 10936147.
43. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003, 374:1-20. 10.1042/BJ20030407, 1223585, 12773095.
44. Tanigawa K, Suzuki K, Kimura H, Takeshita F, Wu H, Akama T, Kawashima A, Ishii N. Tryptophan aspartate-containing coat protein (CORO1A) suppresses Toll-like receptor signalling in Mycobacterium leprae infection. Clin Exp Immunol 2009, 156:495-501. 10.1111/j.1365-2249.2009.03930.x, 2691979, 19438603.
45. Weldon S, Taggart CC. Innate host defense functions of secretory leucoprotease inhibitor. Exp Lung Res 2007, 33:485-491. 10.1080/01902140701756547, 18075823.
46. Ding A, Thieblemont N, Zhu J, Jin F, Zhang J, Wright S. Secretory leukocyte protease inhibitor interferes with uptake of lipopolysaccharide by macrophages. Infect Immun 1999, 67:4485-4489. 96768, 10456890.
47. Jin F, Nathan C, Radzioch D, Ding A. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 1997, 88:417-426. 10.1016/S0092-8674(00)81880-2, 9039268.
48. Zhang Y, DeWitt DL, McNeely TB, Wahl SM, Wahl LM. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J Clin Invest 1997, 99:894-900. 10.1172/JCI119254, 507897, 9062347.
49. Morath S, Geyer A, Hartung T. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med 2001, 193:393-398. 10.1084/jem.193.3.393, 2195914, 11157059.
50. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 2000, 165:618-622.
51. Wu ZJ, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F. A model-based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc 2004, 99:909-917.
52. Hintermair V. Comparative analysis of Bos taurus and Homo sapiens DNA microarrays. Master thesis 2007, Ludwig Maximilians University, Munich, Germany.
53. Pavlidis P, Noble WS. Matrix2png: a utility for visualizing matrix data. Bioinformatics 2003, 19:295-6. 10.1093/bioinformatics/19.2.295, 12538257.
54. Goldammer T, Zerbe H, Molenaar A, Schuberth HJ, Brunner RM, Kata SR, Seyfert HM. Mastitis increases mammary mRNA abundance of beta-defensin 5, toll-like-receptor 2 (TLR2), and TLR4 but not TLR9 in cattle. Clin Diag Lab Immunol 2004, 11:174-185. 321333, 14715566.